NCT04017962 2025-08-11
A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Memorial Sloan Kettering Cancer Center
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
National Cancer Institute, Egypt
Centre Hospitalier Universitaire de Saint Etienne
GlaxoSmithKline
Apogenix AG
Vanderbilt-Ingram Cancer Center
Arbeitsgemeinschaft medikamentoese Tumortherapie
Centre Francois Baclesse